Reference42 articles.
1. De Servi S, Mariani G, Mariani M, D’Urbano M (2013) The bivalirudin paradox: high evidence, low use. J Cardiovasc Med 14:334–341
2. Lund M, Macwan AS, Tunströmer K, Lindahl TL, Boknäs N (2021) Effects of heparin and bivalirudin on thrombin-induced platelet activation: differential modulation of PAR signaling drives divergent prothrombotic responses. Front Cardiovasc Med 29:717835
3. Van Cott EM, Roberts AJ, Dager WE (2017) Laboratory monitoring of parenteral direct thrombin inhibitors. Semin Thromb Hemost 43:270–276
4. Warkentin TE, Greinacher A, Koster A (2008) Bivalirudin. Thromb Haemost 99:830–839
5. Medicines Agency 2016 Bivalirudin 250 mg powder for concentrate for solution for injection or infusion. http://www.medicinces.org.uk/emc/product/7229/smpc/print. Accessed 26 Sept 2022
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献